CN115813822B - 一种高效祛痘组合物及其制备方法 - Google Patents
一种高效祛痘组合物及其制备方法 Download PDFInfo
- Publication number
- CN115813822B CN115813822B CN202211625333.4A CN202211625333A CN115813822B CN 115813822 B CN115813822 B CN 115813822B CN 202211625333 A CN202211625333 A CN 202211625333A CN 115813822 B CN115813822 B CN 115813822B
- Authority
- CN
- China
- Prior art keywords
- salicylic acid
- acne
- epoxy
- polyether trisiloxane
- trisiloxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 72
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 71
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 128
- 239000004721 Polyphenylene oxide Substances 0.000 claims abstract description 57
- 229920000570 polyether Polymers 0.000 claims abstract description 57
- 239000000284 extract Substances 0.000 claims abstract description 56
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 53
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 53
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- -1 trisiloxane modified salicylic acid Chemical class 0.000 claims abstract description 25
- 241000405414 Rehmannia Species 0.000 claims abstract description 21
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 21
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 21
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 21
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 21
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 16
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 claims abstract description 16
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 16
- 239000000230 xanthan gum Substances 0.000 claims abstract description 16
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 16
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000002904 solvent Substances 0.000 claims abstract description 15
- CKZZREIPBTYJEQ-UHFFFAOYSA-N Totarol Natural products C1CC2C(C)(C)CCCC2(C)C2=C1C(C(C)C)=C(C)C=C2 CKZZREIPBTYJEQ-UHFFFAOYSA-N 0.000 claims abstract description 11
- ZRVDANDJSTYELM-FXAWDEMLSA-N totarol Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)C1=C2C(C(C)C)=C(O)C=C1 ZRVDANDJSTYELM-FXAWDEMLSA-N 0.000 claims abstract description 11
- 229940074347 totarol Drugs 0.000 claims abstract description 11
- ZRVDANDJSTYELM-UHFFFAOYSA-N trans-totarol Natural products C1CC2C(C)(C)CCCC2(C)C2=C1C(C(C)C)=C(O)C=C2 ZRVDANDJSTYELM-UHFFFAOYSA-N 0.000 claims abstract description 11
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 claims abstract 3
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 claims description 34
- 238000003756 stirring Methods 0.000 claims description 23
- 235000019082 Osmanthus Nutrition 0.000 claims description 22
- 241000333181 Osmanthus Species 0.000 claims description 22
- APZYKUZPJCQGPP-UHFFFAOYSA-N Tetrahydropiperine Chemical compound C=1C=C2OCOC2=CC=1CCCCC(=O)N1CCCCC1 APZYKUZPJCQGPP-UHFFFAOYSA-N 0.000 claims description 10
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 8
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 4
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 240000006413 Prunus persica var. persica Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 39
- 229920001661 Chitosan Polymers 0.000 abstract description 7
- 229940002713 osmanthus fragrans flower extract Drugs 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 17
- 230000000844 anti-bacterial effect Effects 0.000 description 16
- TZZGHGKTHXIOMN-UHFFFAOYSA-N 3-trimethoxysilyl-n-(3-trimethoxysilylpropyl)propan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCCC[Si](OC)(OC)OC TZZGHGKTHXIOMN-UHFFFAOYSA-N 0.000 description 13
- 235000011187 glycerol Nutrition 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 208000020154 Acnes Diseases 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000003255 anti-acne Effects 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 241000628997 Flos Species 0.000 description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010033733 Papule Diseases 0.000 description 3
- 206010037888 Rash pustular Diseases 0.000 description 3
- 241000405911 Rehmannia glutinosa Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000029561 pustule Diseases 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102000004363 Aquaporin 3 Human genes 0.000 description 2
- 108090000991 Aquaporin 3 Proteins 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 244000242564 Osmanthus fragrans Species 0.000 description 2
- 235000019083 Osmanthus fragrans Nutrition 0.000 description 2
- 241000186429 Propionibacterium Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930185474 acteoside Natural products 0.000 description 2
- FBSKJMQYURKNSU-ZLSOWSIRSA-N acteoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FBSKJMQYURKNSU-ZLSOWSIRSA-N 0.000 description 2
- FBSKJMQYURKNSU-UKQWSTALSA-N acteoside I Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)C=Cc4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O FBSKJMQYURKNSU-UKQWSTALSA-N 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 229940113120 dipropylene glycol Drugs 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 244000005714 skin microbiome Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 2
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000218689 Podocarpus Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000635201 Pumilus Species 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- MWYMHZINPCTWSB-UHFFFAOYSA-N dimethylsilyloxy-dimethyl-trimethylsilyloxysilane Chemical group C[SiH](C)O[Si](C)(C)O[Si](C)(C)C MWYMHZINPCTWSB-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000001483 monosaccharide substituent group Chemical group 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211625333.4A CN115813822B (zh) | 2022-12-16 | 2022-12-16 | 一种高效祛痘组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211625333.4A CN115813822B (zh) | 2022-12-16 | 2022-12-16 | 一种高效祛痘组合物及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115813822A CN115813822A (zh) | 2023-03-21 |
| CN115813822B true CN115813822B (zh) | 2024-06-25 |
Family
ID=85516381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211625333.4A Active CN115813822B (zh) | 2022-12-16 | 2022-12-16 | 一种高效祛痘组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115813822B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118206716A (zh) * | 2024-02-02 | 2024-06-18 | 广州市斯洛柯高分子聚合物有限公司 | 一种有机硅改性热塑性聚氨酯弹性体及其制备方法与应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103585926A (zh) * | 2013-11-22 | 2014-02-19 | 东华大学 | 一种耐酸碱聚醚改性三硅氧烷表面活性剂及其制备和应用 |
| CN111643402A (zh) * | 2020-06-04 | 2020-09-11 | 昆明滇本生物科技有限公司 | 一种含锯叶棕精油的祛痘组合物及其制备方法 |
| CN113413356A (zh) * | 2021-05-07 | 2021-09-21 | 广州摩亚方舟贸易有限公司 | 一种基于桃拓酚的祛痘组合物及其制备方法 |
| CN114053175A (zh) * | 2021-11-13 | 2022-02-18 | 厦门海尼生物科技有限公司 | 一种祛痘产品及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2380675B (en) * | 2000-05-19 | 2004-11-03 | Sabinsa Corp | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
| JP2009234993A (ja) * | 2008-03-27 | 2009-10-15 | Shiseido Co Ltd | サリチル酸又はサリチル酸誘導体を含有する油中水型乳化組成物 |
| CN107890457A (zh) * | 2017-12-11 | 2018-04-10 | 广州赛莱拉干细胞科技股份有限公司 | 一种含有桂花干细胞提取物的增强免疫力、保湿组合物及其制备方法 |
| CN111072754B (zh) * | 2019-12-04 | 2021-10-26 | 常熟理工学院 | 一种三硅氧烷改性肌肽及其制备方法 |
| CN112426398A (zh) * | 2020-12-22 | 2021-03-02 | 广州天翼化妆品有限公司 | 一种具有淡化痘印作用的祛痘组合物及其制备方法 |
| CN113797141A (zh) * | 2021-09-29 | 2021-12-17 | 广州深叶生物科技有限公司 | 一种祛痘组合物及其制备方法和应用 |
| CN114376953B (zh) * | 2022-01-18 | 2023-10-10 | 厦门海尼生物科技有限公司 | 一种祛痘产品及其制备工艺 |
-
2022
- 2022-12-16 CN CN202211625333.4A patent/CN115813822B/zh active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103585926A (zh) * | 2013-11-22 | 2014-02-19 | 东华大学 | 一种耐酸碱聚醚改性三硅氧烷表面活性剂及其制备和应用 |
| CN111643402A (zh) * | 2020-06-04 | 2020-09-11 | 昆明滇本生物科技有限公司 | 一种含锯叶棕精油的祛痘组合物及其制备方法 |
| CN113413356A (zh) * | 2021-05-07 | 2021-09-21 | 广州摩亚方舟贸易有限公司 | 一种基于桃拓酚的祛痘组合物及其制备方法 |
| CN114053175A (zh) * | 2021-11-13 | 2022-02-18 | 厦门海尼生物科技有限公司 | 一种祛痘产品及其制备方法 |
Non-Patent Citations (3)
| Title |
|---|
| 基于环氧氯丙烷醚化改性水杨酸的功能材料的制备;苗宗成等;化工新型材料;20141115;第42卷(第11期);全文 * |
| 壳聚糖改性水杨酸的刺激性和美白功效研究;常思思;董银卯;祝钧;何聪芬;;香料香精化妆品;20100831(04);全文 * |
| 植物黄酮类化合物在化妆品功效应用中的研究进展;刘婷;刘芳;陈亮;余娟;龚盛昭;;广东化工;20200515(09);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115813822A (zh) | 2023-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2155222B1 (en) | Extract of trigonella foenum-graecum | |
| JP4918202B2 (ja) | 皮膚組成物 | |
| WO2002007745A1 (fr) | Compositions antipruritiques et compositions favorisant la suberification des blessures | |
| WO2005009454A1 (ja) | 歯周病治療用及び/又は予防用組成物 | |
| JP2003002811A (ja) | IgE産生抑制剤 | |
| KR100721421B1 (ko) | 항균 및 항진균 활성을 갖는 솔방울 추출물, 및 이를유효성분으로 하는 피부질환 개선용 화장료 조성물 | |
| US5200429A (en) | Acne vulgaris treating | |
| JP2003012489A (ja) | ヒアルロニダーゼ活性阻害剤及び保湿化粧料 | |
| JP3635081B2 (ja) | 美白剤、抗酸化剤、コラゲナーゼ活性阻害剤、ヒアルロニダーゼ活性阻害剤、老化防止剤、皮膚外用剤、化粧料及び食料品 | |
| CN115813822B (zh) | 一种高效祛痘组合物及其制备方法 | |
| JP3002170B2 (ja) | 高品質木酢液原料の製造方法 | |
| EP0970693A1 (en) | Biologically active labdane or labdene derivatives from Cistus | |
| KR101123653B1 (ko) | 여드름 개선을 위한 화장료 조성물 | |
| CN115337211B (zh) | 一种温和低敏性保湿祛痘凝胶及其制备方法 | |
| JP6651104B1 (ja) | 外用組成物の生産方法 | |
| JP2009191019A (ja) | 皮膚若しくは毛髪用化粧料 | |
| JPH01216910A (ja) | 頭髪再生用ローションの製造方法 | |
| KR101274811B1 (ko) | 소엽추출물 및/또는 해금사추출물을 함유하는 여드름 예방및 치료용 조성물 | |
| KR102453167B1 (ko) | 식물성 세라마이드 성분을 함유하는 피부개선용 화장료 조성물 | |
| JP3002166B2 (ja) | 高品質木酢液原料の製造方法 | |
| JPS5913716A (ja) | 外用組成物 | |
| CN114984132B (zh) | 一种促凝促修复的伤口喷雾剂及其制备方法 | |
| JP2000344630A (ja) | 育毛剤原料及びその精製方法並びに育毛剤組成物 | |
| KR19990039050A (ko) | 말벌 독 추출물을 함유하는 여드름 예방 및 치료제 | |
| CN107485644A (zh) | 一种抑菌抗炎剂及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20240228 Address after: Room 404-4, No. 1134 Jimei North Avenue, Software Park Phase III, Xiamen Torch High tech Zone, Xiamen, Fujian Province, 361000 Applicant after: Xiamen Haini Xinchuang Biotechnology Co.,Ltd. Country or region after: China Address before: Room 401, 4th Floor, No. 316, Tongji South Road, Jimei District, Xiamen City, Fujian Province, 361000 Applicant before: XIAMEN HAINI BIO-TECH Co.,Ltd. Country or region before: China |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |